Melatonin to treat sleep disturbances in patients with Alzheimer’s disease

Viacheslav Viktorovich Sushko, Viktor Vasilievich Sushko · 2025

Read Melatonin to treat sleep disturbances in patients with Alzheimer’s disease by Viacheslav Viktorovich Sushko, Viktor Vasilievich Sushko (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11712071.txt.

Description

Viacheslav Viktorovich Sushko and Viktor Vasilievich Sushko test melatonin for poor sleep in Alzheimer's disease in a 2025 study. Broken sleep is common in the disease and can worsen its other symptoms. The pair studied twenty-three patients aged sixty-five to seventy-four, all of whom reported bad sleep.

Patients spent a monitored night in a sleep ward before and after four weeks of a small nightly melatonin dose. At first their sleep stages were short and choppy, with three or four wakings a night. After treatment, most patients' sleep stages matched age norms and sleep lasted longer. Wakings fell to one or two, and people fell back asleep more easily. Some still woke early and felt drowsy by day.

Catalog record

CREATORViacheslav Viktorovich Sushko, Viktor Vasilievich Sushko
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE2 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11712071

Browse the full library · About the Tower of Babel